A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy
Conditions
C3 Glomerulopathy (C3G) · Healthy Adult Participants
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Medizinische Universität Wien, Vienna, Austria
Cliniques universitaires Saint-Luc, Brussels, Belgium
Fakultni Thomayerova nemocnice, Prague, Czechia
Hôpital Européen Georges-Pompidou HEGP, Paris, France
Centre Hospitalier Universitaire De Toulouse, Toulouse, France
Laiko General Hospital Of Athens, Athens, Greece
Pauls Stradins Clinical University Hospital, Riga, Latvia
Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
Amsterdam UMC Stichting, Amsterdam, Netherlands
Hospital Curry Cabral - Centro Hospitalar de Lisboa Central - ULS Sao José, Lisbon, Portugal
Fundacio Puigvert, Barcelona, Spain
Hospital Universitario 12 De Octubre, Madrid, Spain
Clinica Universidad De Navarra, Pamplona, Spain
Hospital Universitario Virgen De La Macarena, Seville, Spain
University Hospital Virgen Del Rocio S.L., Seville, Spain
Karolinska University Hospital, Huddinge, Sweden
Study leads
Bernd Jilma, Prof.
Principal Investigator
Medical University of Vienna